Drugs

Biovail, Valeant Agree to Merge

Stock quotes in this article:BVF, VRX 

TORONTO (TheStreet) --- Specialty drugmakers Biovail(BVF) and Valeant(VRX) have agreed to merge.

The combined company will be called Valeant Pharmaceuticals International. The new Valeant will have a "significantly expanded presence in North America and operations in eight other countries, working across four growth platforms," the companies said in a statement Monday.

Under the terms of the merger, Valeant stockholders will receive 1.7809 Biovail shares for each Valeant share they own plus a one-time special cash dividend of $16.77 a share.

Upon completion of the merger, which is expected to occur before the end of 2010, Biovail stockholders will own about 50.5% of the combined company while Valeant stockholders will own roughly 49.5%.

The companies said they will pay by Dec. 31 an additional dividend of $1 a share, after which the new Valeant doesn't intend to pay dividends.

-- Reported by Joseph Woelfel in New York.

Follow TheStreet.com on Twitter and become a fan on Facebook.

>To order reprints of this article, click here: Reprints

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,454.83 1,317.82 2,837.53 17.45
Oil *
107.26
DOWN
74.92
DOWN
2.86
DOWN
1.85
DOWN
0.14
10 Yr
1.74%
SPDR Gold
152.68
-0.60%
-0.22%
-0.07%
-0.80%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet